| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 36 securities · passive | ||||||
|
Retension Pharmaceuticals, Inc.
13G
RTSN · 76135H100
|
7.4% |
10/15/2026
Event 10/13/2026
|
||||
|
Birchtech Corp.
13G
BCHT · 59833H200
|
5.2% |
10/5/2026
Event 9/29/2026
|
||||
|
Health In Tech, Inc.
13G
HIT · 42217D102
|
6.2% |
9/29/2026
Event 3/27/2026
|
||||
|
Rank One Computing Corp
13G
ROC · 753040104
|
5.1% |
8/20/2026
Event 8/14/2026
|
||||
|
MDxHealth SA
13G/A
MDXH · B5950S113
|
19.5% |
8/17/2026
Event 8/13/2026
|
||||
| Laurence W. Lytton | 19.5% | |||||
| Lytton-Kambara Foundation | 12.1% | |||||
|
Aytu BioPharma, Inc.
13G/A
AYTU · 054754858
|
4.99% |
8/14/2026
Event 6/30/2026
|
||||
| Lytton Laurence W | 4.99% | |||||
| Lytton-Kambara Foundation | 4.99% | |||||
|
LiqTech International, Inc.
13G/A
LIQT · 53632A300
|
10.0% |
8/13/2026
Event 6/30/2026
|
||||
| Lytton Laurence W | 10.0% | |||||
| Lytton-Kambara Foundation | 7.3% | |||||
|
Aprea Therapeutics, Inc.
13G/A
APRE · 03836J201
|
3.2% |
8/13/2026
Event 6/30/2026
|
||||
|
IN8BIO, Inc.
13G/A
INAB · 45674E208
|
10.0% |
8/13/2026
Event 6/30/2026
|
||||
| Lytton Laurence W | 10.0% | |||||
| Lytton-Kambara Foundation | 10.0% | |||||
|
Capstone Energy Plus, Inc.
13G/A
CEPL · 14067D607
|
5.4% |
8/13/2026
Event 6/30/2026
|
||||
| Lytton Laurence W | 5.4% | |||||
| Lytton-Kambara Foundation | 4.5% | |||||
|
DNA X, Inc.
13G/A
SONM · 83548F309
|
6.8% |
8/13/2026
Event 6/30/2026
|
||||
|
Codexis, Inc.
13G/A
CDXS · 192005106
|
5.2% |
8/13/2026
Event 6/30/2026
|
||||
|
Scientific Industries Inc
13G/A
SCND · 808757108
|
9.9% |
8/13/2026
Event 6/30/2026
|
||||
| Lytton Laurence W | 10.0% | |||||
| Lytton-Kambara Foundation | 9.9% | |||||
|
Ideal Power Inc.
13G/A
IPWR · 451622203
|
7.5% |
8/13/2026
Event 6/30/2026
|
||||
|
Rein Therapeutics, Inc.
13G/A
RNTX · 00887A204
|
4.9% |
8/13/2026
Event 6/30/2026
|
||||
|
Guerrilla RF, Inc.
13G/A
GUER · 40162G203
|
10.0% |
8/13/2026
Event 6/30/2026
|
||||
|
Data I/O Corp
13G
DAIO · 237690102
|
9.9% |
6/23/2026
Event 6/17/2026
|
||||
| Lytton Laurence W | 9.9% | |||||
| Lytton-Kambara Foundation | 5.8% | |||||
| AWL Family LLC | 2.9% | |||||
|
Sintx Technologies, Inc.
13G
SINT · 829392703
|
10.0% |
6/9/2026
Event 6/3/2026
|
||||
| Lytton Laurence W | 10.0% | |||||
| Lytton-Kambara Foundation | 10.0% | |||||
|
Talphera, Inc.
13G/A
TLPH · 00444T209
|
2.5% |
5/15/2026
Event 3/31/2026
|
||||
| Lytton Laurence W | 2.5% | |||||
| Lytton-Kambara Foundation | 2.5% | |||||
|
TELA Bio, Inc.
13G/A
TELA · 872381108
|
5.5% |
5/15/2026
Event 3/31/2026
|
||||
|
Creative Realities, Inc.
13G/A
CREX · 22530J309
|
8.7% |
5/15/2026
Event 3/31/2026
|
||||
|
Liberty Defense Holdings, Ltd.
13G
DETX · 53044R867
|
9.9% |
4/27/2026
Event 4/22/2026
|
||||
|
Stryve Foods, Inc.
13G/A
SNAX · 863685202
|
10.0% |
2/17/2026
Event 12/31/2025
|
||||
| Lytton Laurence W | 10.0% | |||||
| Lytton-Kambara Foundation | 10.0% | |||||
|
Xtant Medical Holdings, Inc.
13G/A
XTNT · 98420P308
|
5.5% |
2/17/2026
Event 12/31/2025
|
||||
| Lytton Laurence W | 5.5% | |||||
| Lytton-Kambara Foundation | 5.0% | |||||
|
Elauwit Connection, Inc.
13G
ELWT · 28417M109
|
5.9% |
12/22/2025
Event 12/15/2025
|
||||
|
scPharmaceuticals Inc.
13G/A
SCPH · 810648105
|
0% |
11/14/2025
Event 9/30/2025
|
||||
|
Cellectar Biosciences, Inc.
13G/A
CLRB · 15117F880
|
1.6% |
8/14/2025
Event 6/30/2025
|
||||
|
Electrovaya Inc.
13G/A
ELVA · 28617B606
|
4.7% |
8/14/2025
Event 6/30/2025
|
||||
|
Exagen Inc.
13G/A
XGN · 30068X103
|
1.0% |
8/14/2025
Event 6/30/2025
|
||||
|
Evoke Pharma Inc
13G/A
EVOK · 30049G302
|
3.9% |
5/15/2025
Event 3/31/2025
|
||||
|
SmartKem, Inc.
13G/A
SMTK · 83193D203
|
4.9% |
5/15/2025
Event 3/31/2025
|
||||
|
NEUROONE MEDICAL TECHNOLOGIES Corp
13G/A
NMTC · 64130M209
|
2.6% |
5/15/2025
Event 3/31/2025
|
||||
|
Biofrontera Inc.
13G/A
BFRI · 09077D209
|
3.5% |
5/15/2025
Event 3/31/2025
|
||||
|
Cellectar Biosciences, Inc.
13G/A
CLRB · 15117F807
|
8.8%
Checked 5% or less
|
2/13/2025
Event 12/31/2024
|
||||
|
Duos Technologies Group, Inc.
13G/A
DUOT · 266042407
|
4.99% |
2/13/2025
Event 1/31/2024
|
||||
|
Emcore Corp
13G/A
EMKR · 290846401
|
1.4% |
2/13/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.